Pinterest • The world’s catalogue of ideas
from musculardystrophynews.com

Duchenne Muscular Dystrophy Treatment Receives Pediatric Disease Status from FDA

Duchenne Muscular Dystrophy Treatment Receives Pediatric Disease Status from FDA Marathon Pharmaceuticals' Deflazacort issued rare designation, new drug application planned for 2016

from musculardystrophynews.com

New Drug Application Filed for Sarepta’s Eteplirsen for Duchenne Muscular Dystrophy Treatment

from musculardystrophynews.com

FDA Grants Fast Track Designation To Tarix Orphan LLC's TXA127 as Promising Duchenne Muscular Dystrophy Treatment

FDA Grants Fast Track Designation To Tarix Orphan LLC’s TXA127 as Promising Duchenne Muscular Dystrophy Treatment

from Muscular Dystrophy News

Duchenne Muscular Dystrophy Might Be Treatable with Cancer Drug

Read about a study finding a drug used to treat leukemia  might be a potential therapy to slow the progression of Duchenne muscular dystrophy.

The newly released American Academy of Neurology guideline for limb-girdle MD and some forms of distal MD emphasizes accurate diagnosis, as well as detection and treatment of cardiac and respiratory abnormalities. by: Margaret Wahl on October 29, 2014 http://quest.mda.org/news/aan-releases-guideline-lgmd-diagnosis-and-care

from musculardystrophynews.com

Duchenne Muscular Dystrophy Trial Design May Mask Treatment Effectiveness

from Muscular Dystrophy News

Bisphosphonate Treatment in Duchenne Muscular Dystrophy Leads to Decrease in Bone Turnover in Pediatric Patients

Read about a Study comparing before and after effects of bisphosphonate treatment in bone tissue structure and bone matrix mineralization in boys with Duchenne muscular dystrophy